Author:
Yan Guanzhong,Yao Ruyong,Tang Dongfang,Qiu Tong,Shen Yi,Jiao Wenjie,Ge Nan,Xuan Yunpeng,Wang Yongjie
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference30 articles.
1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics. CA Cancer J Clin. 2001;51:15–36.
2. Tanner NT, Mehta H, Silvestri GA. New testing for lung cancer screening. Oncology. 2012;26:176–82.
3. Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol. 2003;22:330–53.
4. Yilmaz A, Damadoglu E, Salturk C, Okur E, Tuncer LY, et al. Delays in the diagnosis and treatment of primary lung cancer: are longer delays associated with advanced pathological stage? Ups J Med Sci. 2008;113:287–96.
5. Yang G, Yao Y, Zhou J, Zhao Q. Effects of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in EGFR-mutated non-small cell lung cancer. Oncol Rep. 2012;6:2066–72.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献